Carregant...
A New Class of Adjuvants Enables Lower Dosing of Colistin Against Acinetobacter baumannii
Antibiotic resistance has become increasingly prevalent over the past few decades, and this combined with a dearth in the development of new classes of antibiotics to treat multidrug resistant Gram-negative infections has led to a significant global health problem and the increased usage of colistin...
Guardat en:
| Publicat a: | ACS Infect Dis |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6480319/ https://ncbi.nlm.nih.gov/pubmed/29890069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsinfecdis.8b00103 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|